Eric Hoste retweeted
Last week, this marvelous team celebrated 1500 liver transplantations in @uzgent. Expertise, engagement and most of all collaboration are key for success.
Eric Hoste retweeted
For World Kidney Day can we please FIX THE MATH @ISNkidneycare claims only 13m people sustain AKI annually but it's really about 100m. In the US about 11% of hospitalizations have AKI or about 90 per 10,000 person yrs. If we include AKD, rates are above 130 per 10,000 person yrs
Eric Hoste retweeted
🏆 Top cited @yourICM articles published this year
🥈 with 20 citations in 2023 (really close to 1st place)
🧫@EuroBact2 study on hospital‑acquired bloodstream infections in #ICU, including 2600 pts, 699 contributors from 333 ICUs/52 countries #FOAMcc
🔓 rdcu.be/c5nEP
Eric Hoste retweeted
Our new publication in @Crit_Care🍾
How often is significant mortality reduction in single-center trials replicated by subsequent multicenter trials?
Even if you consider monocentric trials published in NEJM/JAMA/Lancet, the probability is only 6%😱
🔓doi.org/10.1186/s13054-023-0…
Eric Hoste retweeted
The first participant was enrolled in the LIMIT trial - RCT comparing Low and Medium Intensity CRRT. Significant step forward😀
Eric Hoste retweeted
Presented at #LIVES2023:
In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia.
Full AMIKINHAL trial results: nej.md/472lySJ
Eric Hoste retweeted
📣 2 major new REMAP-CAP papers were released moments ago!
📄 Intravenous #VitaminC for Patients Hospitalized with #COVID19: Two Harmonized Randomized Clinical Trials 👉 jamanetwork.com/journals/jam…
📄 #Simvastatin in Critically Ill Patients with COVID-19 👉 nejm.org/doi/full/10.1056/NE…
Eric Hoste retweeted
👇Free access to our methylene blue meta-analysis recently published in @JCVAonline
Additional evidence in favor of multimodal vasopressor therapy✨
🔓authors.elsevier.com/c/1hzYp…
#FOAMcc
Our new publication‼️
Methylene blue in critically ill and perioperative settings: a meta-analysis of RCTs
Compared to placebo/usual care alone, methylene blue was associated with significantly reduced mortality in either a random or fixed effects model.
jcvaonline.com/article/S1053…
Eric Hoste retweeted
Presented at #LIVES2023:
In this open-label, randomized trial in patients newly receiving mechanical ventilatory support for Covid-19–associated ARDS, those who received convalescent plasma had lower 28-day mortality than those who received standard care.
Full study:
🫁Convalescent plasma against COVID-19 reduced mortality in COVID-19 patients on mechanical ventilation. Proud to have been part of this Belgian PRCT run by Benoit Misset and presented at #LIVES2023
🔓tinyurl.com/yat4aru4
@ESICM @NEJM @KCEfgov @RodeKruisVL
Eric Hoste retweeted
If we can make reviewers smile😄, we will be able to smile 😊
How to deal with reviewers' comments and successful publication
By @PPovoa3
Eric Hoste retweeted
👏 Prof Antonio Artigas is the recipient of this year's ESICM Society Medal. He is a founding member of ESICM & his dedication & expertise over +40 years have allowed him to witness the evolution of #CriticalCare medicine & remain an active participant in its advancement.
Eric Hoste retweeted
AKI
#LIVES2023 #ESICM
@KatiaDonadello @EricHoste
@JohnProwle: serum creatinine is an inappropriate measure in our patient cohort
NB- Creatinine in Spinal Injury patients hopeless! #NeuroICM #AKI
Eric Hoste retweeted
this is a beautiful Figure @romsonnevil
#CritCare #OpenAccess
The spectrum of sepsis-associated encephalopathy: a clinical perspective
Read the full article: doi.org/10.1186/s13054-023-0…
@jlvincen @ISICEM #FOAMed #FOAMcc
Eric Hoste retweeted
The @ESICM VITAL project to improve #ICU care just launched at #LIVES2023
📢 Voice of patients & family members
🌈 Inclusion, diversity, empowerment
🤝Together, partnership, value
🛟 Alliance:collaboration
🔗 Linking: creating peer community
#togetherweareICU but with patients, who are persons & family members, being part of that
Eric Hoste retweeted
Second day of @ESICM @EuroELSO #ECMO #simulation workshop is about to start here in Milan at #LIVES2023!!
#simulation training tomorrow
🩸cannulation
🫁 veno-venous #ECMO &
🫀veno-arterial #ECLS scenarios
⚙️ #extracorporeal circuit & troubleshooting complications
How to use Social Media to promote your research. Great talk at #LIVES2023 by Marta Velia Antonini @FOAMecmo @ESICM
